Tougher fines for possession don’t solve the problems that enable gangs to move in to cities like Marseille.
Articles on Drugs
Displaying 21 - 40 of 550 articles
We’re outraged that the Enhanced Games allows doping, yet fans happily watch boxers suffer brain damage. The real scandal is the hypocrisy about athletic harm.
It isn’t new but stronger drugs and faster absorption mean boofing carries risks many people don’t realise.
Before you spend your money, here’s why you should think twice about buying a weight-loss patch.
New research suggests overdose prevention and supervised consumption sites are not consistently associated with increases in local crime.
The disappearance of 500-euro notes and the creation of bitcoin have led money laundering networks to pay drug traffickers in cryptocurrencies and ship cash to Dubai (United Arab Emirates).
There is no evidence that US intervention in Venezuela will lead to a meaningful reduction in drugs flowing into the United States.
Researchers identified a key molecule that highlights how the immune system is linked to the release of dopamine.
Many health symptoms can be caused by multiple illnesses – if AI can’t tell the difference between them, it won’t be able to operate accurately without human oversight.
The art market attracts money-laundering activities. How can it better protect itself?
Fifty years after its major drug law was introduced, NZ still lacks a clear picture of the harm drugs do. Asking drug users themselves offers surprising insights.
Legal drugs mimic popular substances. But when one is banned, another quickly takes its place.
US military buildup in the Caribbean has prompted Venezuelan President Nicolás Maduro to reciprocate with military drills.
Pharmacogenomic testing can tell how a drug is likely to work in a certain person. But is it ready for rolling out to the wider population?
Cancer. Diabetes. Aging itself. Rapamycin’s potential to treat an array of diseases has been a source of scientific fascination. But many aren’t aware of its origins – and its complicated legacy.
From tigers to mice and penguins to elephants – animal pharmacologists analyze samples from them all and play an important role in devising treatment plans.
Adulterated drugs and a shortage of pill testing services is making it hard for people who use drugs to stay safe. But they’re taking matters into their own hands.
These synthetic opioids are taking over from fentanyl, but even a tiny dose can be lethal.
By extending their monopoly on a drug, companies prevent generics and other competitors from driving down prices. But increasing transparency can help prevent Big Pharma from gaming the patent system.
Researchers hope that transparency around where the money is going will help counties use the funds more effectively.
Top contributors
-
Honorary Fellow, Department of Health Sciences, University of York
-
Adjunct Professor at the National Drug Research Institute (Melbourne based), Curtin University
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Senior Lecturer of Addiction, Edith Cowan University
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Professor in Substance Use, Liverpool John Moores University
-
Associate Professor, National Drug Research Institute / enAble Institute, Curtin University
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor in Criminal Justice and Faculty Director of Public Engagement, University of Kent
-
Senior Lecturer in Criminology, Swansea University
-
Senior Lecturer in Chemistry, University of Birmingham
-
PhD Candidate, Royal Holloway, University of London
-
Lecturer, RMIT University
-
University of Sydney
-
Associate Professor in Pharmacy Practice, Kingston University